Press Releases

Press Releases

March 21, 2022
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
March 17, 2022
ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call
March 8, 2022
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
February 2, 2022
ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference
January 25, 2022
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications
January 10, 2022
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
January 4, 2022
ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
Displaying 11 - 17 of 17